Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.42 |
| ▸ | CA2 | P00918 | 8/20 | 0.42 |
| ▸ | CA9 | Q16790 | 7/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | IDE | P14735 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16650007 | 0.87 | CYP3A4 (0.46) | CA1CA2CA9CA4CA6 | |
| SCHEMBL21487375 | 0.83 | CA2 (0.61) | CA1CA2CA9CA12CA4 | |
| SCHEMBL17200426 | 0.81 | GAA (0.41) | CA1CA2CA9CA12CA4 | |
| SCHEMBL17208681 | 0.79 | CA1 (0.39) | CA1CA2CA9CA12CA4 | |
| SCHEMBL17200503 | 0.79 | MAPT (0.42) | CA1CA2CA9CA12CA4 | |
| SCHEMBL9350559 | 0.79 | CA2 (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL20917372 | 0.78 | CA1 (0.43) | CA1CA2CA9ENPP2WDR5 | |
| SCHEMBL17213570 | 0.78 | GAA (0.54) | CA1CA2CA9CA12G6PD | |
| SCHEMBL11824069 | 0.78 | CA12 (0.41) | CA1CA2CA9CA12G6PD | |
| SCHEMBL10710003 | 0.76 | AKR1C4 (0.56) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092065-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | INCYTE CORP (US) | 2026-04-02 | — | — | US | disclosed |
| US-12459943-B2 | Crystalline solid forms of a BET inhibitor | INCYTE CORPORATION (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250145621-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE HOLDINGS CORPORATION | 2025-05-08 | — | — | US | disclosed |
| US-12227502-B2 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as inhibitors of BET proteins | INCYTE CORPORATION (US) | 2025-02-18 | — | — | US | disclosed |
| US-20240309001-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | INCYTE CORPORATION | 2024-09-19 | — | — | US | disclosed |
| US-12030882-B2 | Crystalline solid forms of a bet inhibitor | INCYTE CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240002381-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION | 2024-01-04 | — | — | US | disclosed |
| EP-4234554-A2 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | Incyte Corporation (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4234554-A2 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | Incyte Corporation (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4218766-A1 | 1H-PYRROLO[2,3-C]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-C]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | Incyte Holdings Corporation (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-3134403-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | Incyte Corporation (US) | 2017-03-01 | — | — | EP | disclosed |
| CN-106414442-A | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | 因赛特公司 | 2017-02-15 | — | — | CN | disclosed |
| US-9540368-B2 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | INCYTE CORPORATION (US) | 2017-01-10 | — | — | US | disclosed |
| US-9540368-B2 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | INCYTE CORPORATION (US) | 2017-01-10 | — | — | US | disclosed |
| US-9540368-B2 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | INCYTE CORPORATION (US) | 2017-01-10 | — | — | US | disclosed |
| US-20150307493-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150307493-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| WO-2015164480-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION (US) | 2015-10-29 | — | — | WO | disclosed |
| US-20150307493-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| WO-2015164480-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | INCYTE CORPORATION (US) | 2015-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030882-B2 | Crystalline solid forms of a bet inhibitor | BRD1, BRD3, BRD2 | CA1 3670/4885CA2 4071/4885CA9 3374/4885 |
| US-12459943-B2 | Crystalline solid forms of a BET inhibitor | BRD1, BRD3, BRD2 | CA1 3670/4885CA2 4071/4885CA9 3374/4885 |
| US-20240002381-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | BRD3, BRD1, BRD2 | CA1 4874/4885CA2 4825/4885CA9 4758/4885 |
| US-20250145621-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | BRD3, BRD1, BRD2 | CA1 4874/4885CA2 4825/4885CA9 4758/4885 |
| US-20150307493-A1 | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | BRD3, BRD1, BRD2 | CA1 4874/4885CA2 4825/4885CA9 4758/4885 |
| US-20260092065-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | BRD2, BRDT, BRD1 | CA1 4052/4885CA2 4427/4885CA9 3616/4885 |
| US-20240309001-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | BRD1, BRD3, BRD2 | CA1 3670/4885CA2 4071/4885CA9 3374/4885 |
| US-12227502-B2 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as inhibitors of BET proteins | BRD3, BRD1, BRD2 | CA1 4874/4885CA2 4825/4885CA9 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.